At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
AMPK-sensing energy while talking to other signaling pathways
Tirzepatide adds the GIP component
Thursday's stock moves could point to concerns about the new product's impact, as well as responses to its launch
Some dermatologists use microneedling or sonophoresis to push vitamin C and other antioxidants deeper into the skin
Monitor for pain, bruising, swelling, warmth, a lump, or worsening irritation, and contact a healthcare professional if anything concerns you